| Title | Consultation response to the Medicines and Healthcare Products Regulatory Agency (MHRA) on 'Consultation MLX 343 - Proposals to make the sale and supply of products containing more than 720mg pseudoephedrine and 180mg ephedrine subject to prescription' |